Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 658.42M | 683.68M | 616.98M | 603.64M | 479.71M |
Gross Profit | 94.79M | 97.48M | 87.01M | 85.51M | 71.64M |
EBITDA | 39.25M | 42.64M | 28.14M | 38.36M | 28.46M |
Net Income | 27.12M | 30.82M | 20.00M | 24.96M | 17.78M |
Balance Sheet | |||||
Total Assets | 402.43M | 381.61M | 329.30M | 298.44M | 273.41M |
Cash, Cash Equivalents and Short-Term Investments | 83.82M | 73.54M | 69.54M | 74.41M | 77.65M |
Total Debt | 2.19M | 2.69M | 3.42M | 5.01M | 7.60M |
Total Liabilities | 248.22M | 237.40M | 192.21M | 168.25M | 146.58M |
Stockholders Equity | 155.25M | 145.25M | 137.10M | 130.20M | 114.53M |
Cash Flow | |||||
Free Cash Flow | 36.12M | 24.84M | 10.97M | 25.78M | 45.85M |
Operating Cash Flow | 36.64M | 25.19M | 12.12M | 26.95M | 47.14M |
Investing Cash Flow | 128.00K | -304.00K | -939.00K | -896.00K | -1.59M |
Financing Cash Flow | -27.29M | -20.35M | -14.50M | -20.15M | -27.18M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | €281.10M | 9.12 | 22.42% | 9.10% | ― | ― | |
63 Neutral | $34.04B | 6.14 | -11.52% | 1.82% | 5.53% | -18.79% | |
$176.87M | 21.13 | 25.02% | 5.13% | ― | ― | ||
79 Outperform | S$451.50M | 6.40 | 20.62% | 34.19% | -30.65% | -29.55% | |
69 Neutral | S$542.40M | 14.61 | 8.89% | 2.63% | 6.93% | 14.19% | |
64 Neutral | S$324.02M | 29.20 | 8.66% | 0.31% | 43.32% | 96.93% | |
55 Neutral | S$466.93M | 39.62 | 2.40% | ― | -20.96% | ― |
Multi-Chem Limited held its Annual General Meeting on April 25, 2025, in Singapore, where key company directors and shareholders were present. The meeting was chaired by Mr. Chong Teck Sin, and all resolutions were voted on by poll, with Entrust Advisory Pte Ltd appointed as the scrutineer. The Chairman exercised his right to demand poll voting for all resolutions and ensured that proxy votes were cast in accordance with shareholders’ instructions.
Multi-Chem Limited has announced a change in its financial reporting schedule, moving from quarterly to half-yearly reporting of unaudited financial statements, starting from the financial year ending December 31, 2025. This strategic shift is aimed at consolidating resources in a challenging economic environment to foster continued growth and value creation, while maintaining compliance with disclosure obligations to keep shareholders informed of any significant developments.